Literature DB >> 28574875

Augmenting Amyloid PET Interpretations With Quantitative Information Improves Consistency of Early Amyloid Detection.

Nicholas R Harn1, Suzanne L Hunt, Jacqueline Hill, Eric Vidoni, Mark Perry, Jeffrey M Burns.   

Abstract

PURPOSE: Establishing reliable methods for interpreting elevated cerebral amyloid-β plaque on PET scans is increasingly important for radiologists, as availability of PET imaging in clinical practice increases. We examined a 3-step method to detect plaque in cognitively normal older adults, focusing on the additive value of quantitative information during the PET scan interpretation process.
METHODS: Fifty-five F-florbetapir PET scans were evaluated by 3 experienced raters. Scans were first visually interpreted as having "elevated" or "nonelevated" plaque burden ("Visual Read"). Images were then processed using a standardized quantitative analysis software (MIMneuro) to generate whole brain and region of interest SUV ratios. This "Quantitative Read" was considered elevated if at least 2 of 6 regions of interest had an SUV ratio of more than 1.1. The final interpretation combined both visual and quantitative data together ("VisQ Read"). Cohen kappa values were assessed as a measure of interpretation agreement.
RESULTS: Plaque was elevated in 25.5% to 29.1% of the 165 total Visual Reads. Interrater agreement was strong (kappa = 0.73-0.82) and consistent with reported values. Quantitative Reads were elevated in 45.5% of participants. Final VisQ Reads changed from initial Visual Reads in 16 interpretations (9.7%), with most changing from "nonelevated" Visual Reads to "elevated." These changed interpretations demonstrated lower plaque quantification than those initially read as "elevated" that remained unchanged. Interrater variability improved for VisQ Reads with the addition of quantitative information (kappa = 0.88-0.96).
CONCLUSIONS: Inclusion of quantitative information increases consistency of PET scan interpretations for early detection of cerebral amyloid-β plaque accumulation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28574875      PMCID: PMC5491352          DOI: 10.1097/RLU.0000000000001693

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  13 in total

1.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Cognitive and functional patterns of nondemented subjects with equivocal visual amyloid PET findings.

Authors:  P Payoux; J Delrieu; A Gallini; D Adel; A S Salabert; A Hitzel; C Cantet; M Tafani; D De Verbizier; J Darcourt; Ph Fernandez; J Monteil; I Carrié; T Voisin; S Gillette-Guyonnet; M Pontecorvo; B Vellas; S Andrieu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-05-08       Impact factor: 9.236

3.  [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease.

Authors:  M A Mintun; G N Larossa; Y I Sheline; C S Dence; S Y Lee; R H Mach; W E Klunk; C A Mathis; S T DeKosky; J C Morris
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

4.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

5.  Visual-statistical interpretation of (18)F-FDG-PET images for characteristic Alzheimer patterns in a multicenter study: inter-rater concordance and relationship to automated quantitative evaluation.

Authors:  T Yamane; Y Ikari; T Nishio; K Ishii; K Ishii; T Kato; K Ito; D H S Silverman; M Senda; T Asada; H Arai; M Sugishita; T Iwatsubo
Journal:  AJNR Am J Neuroradiol       Date:  2013-08-01       Impact factor: 3.825

6.  Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects.

Authors:  Abhinay D Joshi; Michael J Pontecorvo; Chrisopher M Clark; Alan P Carpenter; Danna L Jennings; Carl H Sadowsky; Lee P Adler; Karel D Kovnat; John P Seibyl; Anupa Arora; Krishnendu Saha; Jason D Burns; Mark J Lowrey; Mark A Mintun; Daniel M Skovronsky
Journal:  J Nucl Med       Date:  2012-02-13       Impact factor: 10.057

7.  Use of Standardized Uptake Value Ratios Decreases Interreader Variability of [18F] Florbetapir PET Brain Scan Interpretation.

Authors:  A P Nayate; J G Dubroff; J E Schmitt; I Nasrallah; R Kishore; D Mankoff; D A Pryma
Journal:  AJNR Am J Neuroradiol       Date:  2015-03-12       Impact factor: 3.825

8.  Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes.

Authors:  Stefanie Schreiber; Susan M Landau; Allison Fero; Frank Schreiber; William J Jagust
Journal:  JAMA Neurol       Date:  2015-10       Impact factor: 18.302

9.  Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.

Authors:  Christopher M Clark; Michael J Pontecorvo; Thomas G Beach; Barry J Bedell; R Edward Coleman; P Murali Doraiswamy; Adam S Fleisher; Eric M Reiman; Marwan N Sabbagh; Carl H Sadowsky; Julie A Schneider; Anupa Arora; Alan P Carpenter; Matthew L Flitter; Abhinay D Joshi; Michael J Krautkramer; Ming Lu; Mark A Mintun; Daniel M Skovronsky
Journal:  Lancet Neurol       Date:  2012-06-28       Impact factor: 44.182

Review 10.  Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease.

Authors:  Gaël Chételat; Renaud La Joie; Nicolas Villain; Audrey Perrotin; Vincent de La Sayette; Francis Eustache; Rik Vandenberghe
Journal:  Neuroimage Clin       Date:  2013-03-05       Impact factor: 4.881

View more
  17 in total

1.  Heuristic scoring method utilizing FDG-PET statistical parametric mapping in the evaluation of suspected Alzheimer disease and frontotemporal lobar degeneration.

Authors:  Jeremy N Ford; Elizabeth M Sweeney; Myrto Skafida; Shannon Glynn; Michael Amoashiy; Dale J Lange; Eaton Lin; Gloria C Chiang; Joseph R Osborne; Silky Pahlajani; Mony J de Leon; Jana Ivanidze
Journal:  Am J Nucl Med Mol Imaging       Date:  2021-08-15

2.  Statistical Parametric Mapping in Amyloid Positron Emission Tomography.

Authors:  Natasha M Smith; Jeremy N Ford; Arsalan Haghdel; Lidia Glodzik; Yi Li; Debra D'Angelo; Arindam RoyChoudhury; Xiuyuan Wang; Kaj Blennow; Mony J de Leon; Jana Ivanidze
Journal:  Front Aging Neurosci       Date:  2022-04-25       Impact factor: 5.702

3.  A high-glycemic diet is associated with cerebral amyloid burden in cognitively normal older adults.

Authors:  Matthew K Taylor; Debra K Sullivan; Russell H Swerdlow; Eric D Vidoni; Jill K Morris; Jonathan D Mahnken; Jeffrey M Burns
Journal:  Am J Clin Nutr       Date:  2017-10-25       Impact factor: 7.045

4.  Optimisation and usefulness of quantitative analysis of 18F-florbetapir PET.

Authors:  Daniel Fakhry-Darian; Neva Hiten Patel; Sairah Khan; Tara Barwick; William Svensson; Sameer Khan; Richard J Perry; Paresh Malhotra; Christopher J Carswell; Kuldip S Nijran; Zarni Win
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

5.  Visual interpretation of [18F]Florbetaben PET supported by deep learning-based estimation of amyloid burden.

Authors:  Ji-Young Kim; Dongkyu Oh; Kiyoung Sung; Hongyoon Choi; Jin Chul Paeng; Gi Jeong Cheon; Keon Wook Kang; Dong Young Lee; Dong Soo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-09-29       Impact factor: 9.236

6.  A 4-Year Follow-Up of Subjects with Visually Equivocal Amyloid Positron Emission Tomography Findings from the Alzheimer's Disease Neuroimaging Initiative Cohort.

Authors:  Minyoung Oh; Minjung Seo; Sun Young Oh; Heeyoung Kim; Byung Wook Choi; Jungsu S Oh; Jae Seung Kim
Journal:  Nucl Med Mol Imaging       Date:  2021-03-04

7.  Evaluation of a visual interpretation method for tau-PET with 18F-flortaucipir.

Authors:  Ida Sonni; Orit H Lesman Segev; Suzanne L Baker; Leonardo Iaccarino; Deniz Korman; Gil D Rabinovici; William J Jagust; Susan M Landau; Renaud La Joie
Journal:  Alzheimers Dement (Amst)       Date:  2020-11-28

8.  Blunted cerebrovascular response is associated with elevated beta-amyloid.

Authors:  Jason-Flor V Sisante; Eric D Vidoni; Kiersten Kirkendoll; Jaimie Ward; Yumei Liu; Sarah Kwapiszeski; Rebecca Maletsky; Jeffrey M Burns; Sandra A Billinger
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-15       Impact factor: 6.200

9.  Derivation and utility of an Aβ-PET pathology accumulation index to estimate Aβ load.

Authors:  Antoine Leuzy; Johan Lilja; Christopher J Buckley; Rik Ossenkoppele; Sebastian Palmqvist; Mark Battle; Gill Farrar; Dietmar R Thal; Shorena Janelidze; Erik Stomrud; Olof Strandberg; Ruben Smith; Oskar Hansson
Journal:  Neurology       Date:  2020-10-19       Impact factor: 9.910

10.  PET amyloid in normal aging: direct comparison of visual and automatic processing methods.

Authors:  Sven Haller; Marie-Louise Montandon; Johan Lilja; Cristelle Rodriguez; Valentina Garibotto; François R Herrmann; Panteleimon Giannakopoulos
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.